XML 37 R27.htm IDEA: XBRL DOCUMENT v3.22.1
NATURE OF THE ORGANIZATION AND BUSINESS (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
Jan. 18, 2022
Oct. 04, 2021
Oct. 04, 2021
Aug. 04, 2021
Jul. 13, 2021
Jun. 08, 2021
Jun. 08, 2021
Jun. 01, 2021
Jun. 01, 2021
Feb. 11, 2021
Feb. 28, 2022
Sep. 30, 2021
Feb. 28, 2021
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
May 13, 2022
Jun. 03, 2021
Feb. 22, 2021
Jan. 22, 2021
Apr. 25, 2019
Jun. 30, 2018
Apr. 01, 2016
Common Stock, Par or Stated Value Per Share                           $ 0.01   $ 0.01     $ 0.01        
Equity Method Investment, Ownership Percentage                                           85.60%  
Payments to Acquire Businesses, Net of Cash Acquired $ 460,000                         $ 1,012,395                
Milestone payments 3,460,000                                            
Conversion of Stock, Amount Converted 507,000                                            
Periodic payments                     $ 500                        
Payments percentage                     15.00%                        
Acquisition closing                     $ 62,500                        
Partnership description         On July 13, 2021, the Company, on behalf of its customers, entered into an agreement to engage Quest Diagnostics Incorporated (“Quest Diagnostics”) as the Company’s laboratory services provider to perform certain clinical laboratory diagnostic services based on orders submitted to Quest Diagnostics by licensed health care providers who are under contract with the Company and are authorized under U.S. federal or state law to order laboratory tests. Patients of LifeMD Inc.’s affiliated providers gain access to more than 150 of the most ordered laboratory tests at preferential prices, and which can be completed in the comfort, safety, and convenience of their home or office or at any one of Quest Diagnostics’ 2,000 facilities                                    
Concentration Risk, Patent and Other Rights, description       Particle Health enables healthcare companies by offering simple, secure access to vital medical data. With Particle Health’s platform, and patient consent, licensed medical providers on the LifeMD primary care platform gain instant access to comprehensive patient health records, therefore enabling best-in-class, personalized care through a deeper understanding of their patients’ medical histories                                      
Proceeds from Issuance of Private Placement   $ 32,000,000 $ 15,000,000.0     $ 60,000,000 $ 60,000,000 $ 15,000,000.0         $ 13,500,000 $ 13,495,270                
Notes payable, current                           63,400   $ 63,400              
Purchase agreement payable               15,000,000.0 $ 15,000,000.0                            
Going concern ability description           Under the 2021 Shelf at the time of effectiveness, the Company had the ability to raise up to $150 million by selling common stock, preferred stock, debt securities, warrants and units. In conjunction with the 2021 Shelf, the Company also entered into the ATM Sales Agreement whereby the Company may offer and sell, from time to time, shares of common stock having an aggregate offering price of up to $60 million. Under the 2021 Shelf, the Company had the ability to raise up to $150 million                   Under the 2021 Shelf at the time of effectiveness, the Company had the ability to raise up to $150 million by selling common stock, preferred stock, debt securities, warrants and units              
New issues                           $ 58,500,000                  
Proceeds from Stock Issuance   55,300,000                                          
Preferred Stock, Par or Stated Value Per Share                           $ 0.0001                  
Common Stock, Shares, Issued                           30,899,469   30,704,434              
Preferred Stock, Dividends Per Share, Declared                           $ 2.21875                  
Percentage of preferred stock liquidation preference                           8.875%                  
Preferred Stock, Liquidation Preference Per Share                           $ 25.00                  
Retained Earnings Accumulated Deficit                           $ 155,997,323   $ 141,921,085              
Subsequent Event [Member]                                              
Cash                                 $ 20,100,000            
Series A Preferred Stock [Member]                                              
Preferred Stock, Shares Issued                           1,400,000   1,400,000              
Preferred Stock, Par or Stated Value Per Share                           $ 0.0001   $ 0.0001              
Underwriting Shares                       210,000                      
Maximum [Member]                                              
Issuance of common stock                           $ 150,000,000                  
Shares And Securities [Member]                                              
Raise up funds           $ 150,000,000 $ 150,000,000                                
Securities Purchase Agreement [Member]                                              
Early Repayment of Subordinated Debt                 15.0                            
Securities Purchase Agreement [Member] | Investors [Member]                                              
Notes payable, current               $ 15,000,000.0 $ 15,000,000.0                            
Purchase of warrants               1,500,000 1,500,000                            
Warrant, exercise price               $ 12.00 $ 12.00                            
Warrant or right, reason for issuance, description               500,000 warrants were issued to the Purchaser upon closing with the remaining 1,000,000 warrants only issued to the Purchaser in increments of 500,000 if the Debenture remains outstanding for twelve and twenty four months, respectively, following the closing date of the June 1, 2021 Purchase Agreement                              
Warrants term                                   3 years          
Debt instrument, term                 3 years                            
ATM Sales Agreement [Member]                                              
Proceeds from Stock Issuance                           59,500,000                  
Shelf Agreement [Member]                                              
Proceeds from Stock Issuance                           $ 32,000,000                  
Preferred Underwriting Agreement [Member]                                              
Preferred Stock, Shares Issued                       1,400,000                      
Preferred Stock, Dividend Rate, Percentage                       8.875%                      
Preferred Underwriting Agreement [Member] | Series A Preferred Stock [Member]                                              
Preferred Stock, Par or Stated Value Per Share                       $ 0.0001                      
Price Per Share                       25.00                      
Common Underwriting Agreement [Member]                                              
Common Stock, Shares, Issued                       3,833,334                      
BRiley Securities Inc [Member]                                              
Common Stock, Shares, Issued                       500,000                      
Purchase Agreement [Member]                                              
Proceeds from Issuance of Private Placement   55,300,000                                          
Sales Agreement [Member]                                              
Proceeds from Issuance of Private Placement   $ 59,500,000                                          
Private Placement [Member] | Securities Purchase Agreement [Member] | Investors [Member]                                              
Common Stock, Par or Stated Value Per Share                   $ 0.01                          
Number of stock issued                   608,696                          
Stock issued price per share                   $ 23.00                          
Proceeds from Issuance of Private Placement                   $ 13,500,000                          
Private Placement [Member] | Securities Purchase Agreement [Member] | Investors [Member] | Purchase Price [Member]                                              
Proceeds from Issuance of Private Placement                   $ 14,000,000.0                          
IPO [Member]                                              
Price Per Share                       6.00                      
IPO [Member] | Common Underwriting Agreement [Member]                                              
Common Stock, Par or Stated Value Per Share                       $ 0.01                      
Work simpli [Member]                                              
Asset Acquisition, Price of Acquisition, Expected                     $ 4,000,000                        
Second Anniversaries[Member]                                              
Milestone payments $ 1,730,000                                            
LegalSimpli Software, LLC [Member]                                              
Voting Interests Acquired                                           51.00%  
Work Simpli Software Llc [Member]                                              
Equity Interest in Acquiree, Percentage                                           51.00%  
Immudyne PR LLC [Member]                                              
Equity Method Investment, Ownership Percentage                                             78.20%
Conversion Labs PR [Member]                                              
Equity Method Investment, Ownership Percentage                                         100.00%    
LegalSimpli Software, LLC [Member]                                              
Equity Method Investment, Ownership Percentage                                       85.60%